Utilisé comme traitement de l'obésité massive, le Wegovy fait l'objet d'une mise en garde par la Société française ...

"Depuis 2023, l’Agence nationale de sécurité du médicament (ANSM) et l’Assurance maladie ont lancé des alertes au sujet du ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Après le succès de l’Ozempic, ce médicament dédié aux personnes diabétiques aux propriétés coupe-faim, le Wegovy, qui est un médicament anti-obésité, est arrivé sur le marché français. Pour l’instant, ...

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

Les autorités des Comores ont arrêté un trafiquant d'êtres humains présumé dans le cadre d'un incident au cours duquel des ...

A new study has found that users of Ozempic or a similar drug had a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than those without a prescription. Fernanda ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Some doctors, along with the U.S. Food and Drug ...

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of chatter over the fact that these meds are really expensive. These drugs ...

Ozempic (semaglutide) is a GLP-1 RA (glucagon-like peptide-1 receptor agonist), also known as a “GLP-1” drug. It’s an effective medication for managing type 2 diabetes and for weight loss.

Dr. Omer Awan is a practicing physician who covers public health. Ozempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in short supply, according to its ...